Aylmer, Canada

Irma Bernatchez-Lemaire

This inventor holds 3 USPTO granted patents. Top assignee: University of Ottawa. Active years: 2005-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Irma Bernatchez-Lemaire. Retrieved from https://idiyas.com/inventor/irma-bernatchez-lemaire

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2005-2007

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Irma Bernatchez-Lemaire: Innovator in Pain Treatment

Introduction

Irma Bernatchez-Lemaire is a prominent inventor based in Aylmer, Canada. She has made significant contributions to the field of pain treatment through her innovative research and development of new compounds. With a total of 3 patents to her name, her work is recognized for its potential impact on medical therapies.

Latest Patents

Irma's latest patents include groundbreaking inventions related to histogranin-like peptides and non-peptides. These inventions focus on new basic amino acid derivatives that are designed for the treatment of pain. The compounds developed by Irma exhibit histogranin-like antinociceptive properties, morphine potentiating effects, and COX-2 induction modulating activities. This innovative approach could lead to more effective pain management solutions.

Career Highlights

Irma is affiliated with the University of Ottawa, where she continues her research and development efforts. Her academic background and dedication to innovation have positioned her as a key figure in her field.

Collaborations

Irma collaborates with notable colleagues, including Simon Lemaire and Hoang-Thanh Le. These partnerships enhance her research capabilities and contribute to the advancement of her projects.

Conclusion

Irma Bernatchez-Lemaire is a trailblazer in the field of pain treatment, with a focus on innovative compounds that could revolutionize medical therapies. Her contributions are invaluable to the scientific community and hold promise for future advancements in pain management.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…